FridayNov 10, 2023 9:00 am

Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders

The agreement with GEDiCube rebrands the company as a wholly-owned subsidiary under the name Renovaro.AI The combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights, and targeted immunotherapies, for cancer and other diseases The AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the largely untapped precision medicine market In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced a definitive agreement…

Continue Reading

ThursdayNov 09, 2023 11:57 am

Brain Cancer Reemergence Could Soon Be Detected Using a Finger-Prick Test

A team of researchers from Nottingham Trent University and the University of Sheffield is developing a first-of-its-kind finger-prick test to test for brain cancer. The research team says the simple test could make it easier to spot recurring brain tumors and even extend the lives of tens of thousands of cancer patients globally. More than 300,000 people worldwide are diagnosed with brain tumors every year, and experts predict that slightly more than 18,000 Americans will lose their lives to brain cancer and central nervous system tumors this year. In addition, even though brain cancer treatments have gotten significantly better over…

Continue Reading

WednesdayNov 08, 2023 10:21 am

Meta-Analysis Says Nutraceuticals Show Potential in Acne Treatment

According to a recent meta-analysis by researchers from the Brigham and Women’s Hospital in Boston, nutraceutical supplements may have the potential to treat acne. The meta-analysis reviewed 42 papers covering how various nutraceuticals affect acne and found that they may play a role in acne treatment in the future. However, researchers behind the meta-analysis say prior studies on the matter aren’t enough and more research is necessary to ascertain the connection between nutraceuticals and acne. Titled "Safety and Effectiveness of Oral Nutraceuticals for Treating Acne — A Systematic Review," the paper analyzed studies that had relatively small sample sizes but…

Continue Reading

TuesdayNov 07, 2023 3:36 pm

Study Finds Autism Compromises Sleep Quality, Physical Activity in Kids

New research has found that children with disorders on the autism spectrum have lower physical activity levels and worse sleep in comparison to their peers. One of the study’s coauthors, Xiao Liang, stated that the study was driven by results from earlier research as well as his experience as an inclusive education teacher in Hong Kong. Liang, who is a research assistant professor in the rehabilitation sciences department at Hong Kong Polytechnic University, added that he discovered that students with autism spectrum disorders (ASD) had low levels of physical activity during class as well as recess and lunch break. For…

Continue Reading

MondayNov 06, 2023 2:17 pm

Sex Hormones Could Influence Alzheimer’s Development, Researchers Say

University of Western Ontario researchers have discovered that sex hormones may play a role in the development of Alzheimer’s disease. The neurodegenerative condition affects roughly 32 million people globally and is characterized by disruptive symptoms such as poor judgment, memory loss and loss of sense of initiative. With two-thirds of Alzheimer’s patients being women, researchers from the University of Western Ontario sought to understand the role of female sex hormones in how the disease develops in the brain. Some researchers posit that women develop Alzheimer’s disease at higher rates because they tend to live longer than men, while others say…

Continue Reading

MondayNov 06, 2023 9:00 am

Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced

Renovaro added Avram Miller, Leni Boeren, Ruud Hendriks, to the company's board of directors The three additions bring extensive financial backgrounds that will help as the company ventures into the new agreement with GEDiCube and Renovaro AI branding Avram Miller believes that Renovaro Bioscience, combined with GEDiCube, has the key elements to play a significant role in transforming AI's impact on medicine Renovaro Biosciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, recently announced a definitive agreement to combine with the advanced AI Company GEDiCube Intl Ltd., rebranding…

Continue Reading

FridayNov 03, 2023 12:57 pm

Australian Study Finds Way to Detect Parkinson’s Prior to Symptom Onset

New research has demonstrated that it is possible to detect signs of Parkinson’s disease through the introduction of a synthetic compound into patients’ bodies. The research was carried out by scientists at the Florey Institute and Austin Health in Australia. The focus of the research was to highlight the changes in the brain that marked disease progression before patients began to present with other symptoms. For their study, the scientists recruited 26 patients with Parkinson’s disease, 11 with rapid eye movement (REM) sleep behavior disorder and 12 others who made up the control group. REM sleep behavior disorder is common…

Continue Reading

FridayNov 03, 2023 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) PRV Sale Prospects Strengthened by Recent Industry Developments

PaxMedica, with the help of financial services firm Bourne Partners, is actively exploring presale of its Priority Review Voucher (“PRV”), highly valuable in the pharmaceutical marketplace once it gets formal approval from the FDA The move is the next step in PaxMedica's ongoing commitment to advancing innovative healthcare solutions for autism patients worldwide Similar successful endeavors in the pharmaceutical landscape have demonstrated lucrative potential PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has set its sights on an exciting potential opportunity. With the engagement of Bourne Partners, a prominent financial services firm specializing in…

Continue Reading

ThursdayNov 02, 2023 1:05 pm

Potential Complications of Untreated Psoriasis

Psoriasis is a skin condition that causes individuals to develop a rash with scaly, itchy patches on their elbows, knees, trunk and scalp. This chronic illness, which may start off as a few itchy patches, can severely affect an individual’s quality of life. Psoriasis is often accompanied by chronic inflammation, which affects those with mild and severe cases alike. Experts agree that in the absence of a cure, proper treatment is required to manage the condition. Below we look at what happens when psoriasis remains untreated and any complications that may arise from undertreating or not treating the condition. What…

Continue Reading

WednesdayNov 01, 2023 10:55 am

Alarming Data Highlights Gaps in Treating People with Chronic HBV

Hepatitis B is a liver infection caused by the hepatitis B virus. This disease, which can be prevented via vaccine, spreads when blood or other body fluids from an infected individual enter the body of another. Having chronic hepatitis B increases an individual’s risk of developing cirrhosis, liver cancer or liver failure. New research, which evaluated a cohort of adult veterans in America, has determined that only about one-half started on antiviral therapy. The study was led by clinical associate professor Robert J. Wong of the Stanford University School of Medicine. The researchers’ aim was to understand chronic hepatitis B-related…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050